Mersana Therapeutics (MRSN) Competitor Comparison
We are evaluating the key criteria listed to compare Mersana Therapeutics (MRSN) against its competitors in the Biotechnology industry.
Market Capitalization
168 / 368Gross Profits
254 / 278Total Revenue
133 / 300EBITDA
282 / 337Free Cashflow
302 / 352Quick Ratio
242 / 357Earnings per Share
112 / 359Dividend yield
0 / 6Total Cash
134 / 358Performance 3 years
217 / 368Performance 5 years
106 / 368Performance 10 years
217 / 368Linearity 3 years
163 / 368Linearity 5 years
2 / 368Linearity 10 years
139 / 368Total Rank
196 / 368Dividend Rank
202 / 368Valuation Rank
217 / 368Piotroski Rank
108 / 368Muliplier Rank
114 / 368Piotroski Rank - MRSN ranking 108 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.